The market leader in sleep apnea testing and treatment
Healthy Sleep Solutions (HSS) is committed to helping people afflicted with sleep apnea live longer, healthier, happier and more fulfilling lives. On the recommendations of independent sleep physicians and under the supervision of their referring doctors, HSS has tested and treated over 100,000 patients and this is growing.
The Healthy Sleep Solutions Patient Pathway is a complete solution for the diagnosis, treatment and ongoing management of obstructive sleep apnea (OSA). Looking after OSA patients is multidisciplinary and may include managing: weight loss, hypertension, type 2 diabetes or depression.
Who we work with
HSS works with an expert team of sleep physicians, other specialists, sleep technicians and reputable treatment providers to deliver positive patient outcomes.
We have an Australia-wide team of sleep services coordinators who liaise with general practitioners and specialists about our service, sleep apnea and sleep studies.
HSS is a wholly owned subsidiary of Air Liquide, a French multinational organisation.The treatment of OSA [obstructive sleep apnea] cannot be limited to any single strategy but requires a multidisciplinary approach, effective provider-patient communications and long-term follow-up to achieve an effective and long-lasting therapeutic success.1 Contact us now
Sleep apnea is a growing problem
One in four Australian adults are at risk of having sleep apnea2 yet 80% remain undiagnosed.3 Sleep apnea severity increases with weight gain.4 As the population gains weight, more people will be at risk.
|Feels regularly tired||75%||81%|
|Average sleep apnea severity||Severe (AHI 30)||Moderate (AHI 23)|
- Overweight / obese and given a weight loss recommendation (83%)
- Diagnosed hypertension (37%)
- Undiagnosed hypertension (10%)
- Uncontrolled hypertension (18.5%)
- Diagnosed T2 diabetes (13%)
- Undiagnosed T2 diabetes6,7 (~10-17%)
- Diagnosed Depression (21%)
References: 1. Romero-Corral, Abel, et al. “Interactions between obesity and obstructive sleep apnea: implications for treatment.” CHEST Journal 137.3 (2010): 711-719. 2. Adams RJ, Piantadosi C, Appleton SL, Hill C, Visvanath R, Wilson DH, McEvoy RD. Investigating obstructive sleep apnoea: will the health system have the capacity to cope? A population study. Aust Health Review 2012; 36(4):424-429. 3. Neville Committee Fatigue and Transport Working Party (Ad hoc sub- committee of the Australasian Sleep Association 03-04) 4. Romero-Corral, Abel, et al. “Interactions between obesity and obstructive sleep apnea: implications for treatment.” CHEST Journal 137.3 (2010): 711-719. 5. Data on file 6. Einhorn, Daniel, et al. “Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus.” Endocrine Practice 13.4 (2007): 355-362. 7. Shaw, Jonathan E., et al. “Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention.” Diabetes research and clinical practice 81.1 (2008): 2-12.